Ulisse Biomed S.p.A. (BIT:UBM)
Italy
· Delayed Price · Currency is EUR 0.788
-0.006 (-0.76%)
Dec 5, 2025, 5:29 PM CET
Ulisse Biomed Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Net Income | -5.3 | -5.94 | -4.8 | -1.31 | -0.6 | 0.22 | Upgrade
|
| Depreciation & Amortization | 3.72 | 2.92 | 2.5 | 0.12 | 0.25 | 0.05 | Upgrade
|
| Other Amortization | -0.69 | - | - | 0.2 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -0.1 | Upgrade
|
| Other Operating Activities | -0.29 | -0.22 | 0.16 | -0.15 | -0.14 | -0.04 | Upgrade
|
| Change in Accounts Receivable | -0.01 | 0.23 | 0.3 | 0.1 | 0.14 | -0.37 | Upgrade
|
| Change in Inventory | 0.17 | 0.19 | -0.25 | -0.04 | -0.02 | 0.01 | Upgrade
|
| Change in Accounts Payable | -0.08 | -0.56 | 1.54 | 0 | -0.07 | 0.14 | Upgrade
|
| Change in Other Net Operating Assets | -0.16 | -0.19 | -0.37 | 0.11 | 0.05 | -0.51 | Upgrade
|
| Operating Cash Flow | -2.65 | -3.56 | -0.91 | -0.97 | -0.39 | -0.6 | Upgrade
|
| Capital Expenditures | -0.01 | -0 | -0.07 | -0.08 | - | -0 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.08 | -0.03 | -0.03 | -0.15 | -0.96 | -0.11 | Upgrade
|
| Investment in Securities | 0.01 | 0.01 | - | - | - | - | Upgrade
|
| Other Investing Activities | - | - | - | - | -0 | -0 | Upgrade
|
| Investing Cash Flow | -0.09 | -0.03 | -0.1 | -0.23 | -0.96 | -0.11 | Upgrade
|
| Short-Term Debt Issued | - | 0.04 | - | - | 0 | - | Upgrade
|
| Total Debt Issued | 0.71 | 0.04 | - | - | 0 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -0 | Upgrade
|
| Total Debt Repaid | 0.06 | - | - | - | - | -0 | Upgrade
|
| Net Debt Issued (Repaid) | 0.76 | 0.04 | - | - | 0 | -0 | Upgrade
|
| Issuance of Common Stock | 1.81 | 2.26 | - | 0 | 6.3 | - | Upgrade
|
| Common Dividends Paid | - | - | - | - | - | -0.02 | Upgrade
|
| Financing Cash Flow | 2.57 | 2.3 | - | 0 | 6.3 | -0.02 | Upgrade
|
| Net Cash Flow | -0.16 | -1.28 | -1.01 | -1.2 | 4.95 | -0.73 | Upgrade
|
| Free Cash Flow | -2.66 | -3.56 | -0.97 | -1.05 | -0.39 | -0.6 | Upgrade
|
| Free Cash Flow Margin | -287.64% | -463.78% | -1470.94% | -757.58% | -140.77% | -99.52% | Upgrade
|
| Free Cash Flow Per Share | -0.11 | -0.14 | -0.04 | -0.13 | -0.05 | - | Upgrade
|
| Cash Income Tax Paid | - | - | - | -0 | - | - | Upgrade
|
| Levered Free Cash Flow | -0.47 | -2.38 | -0.18 | -0.67 | -1.43 | -0.64 | Upgrade
|
| Unlevered Free Cash Flow | -0.46 | -2.36 | -0.18 | -0.67 | -1.42 | -0.64 | Upgrade
|
| Change in Working Capital | -0.09 | -0.32 | 1.23 | 0.17 | 0.1 | -0.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.